Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-25-004492

EVP & Chief Financial Officer acquired 6,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schorno Dean L · EVP & Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-22 Exercise or conversion : show line 1 in the form +1,987 $20.00 $39,740 59,722 D
2025-12-22 Exercise or conversion : show line 2 in the form +2,846 $24.20 $68,873 62,568 D
2025-12-22 Exercise or conversion : show line 3 in the form +1,667 $18.70 $31,173 64,235 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-12-22 Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) −1,987 14,262 D
2025-12-22 Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) −2,846 17,153 D
2025-12-22 Exercise or conversion : show line 6 in the form Employee Stock Option (right to buy) −1,667 10,832 D
Loading xslF345X05/form4.xml…